Publikationen in Zusammenarbeit mit Forschern von Hospital Clínico San Carlos de Madrid (7)

2022

  1. Role of 5HT1A Receptors in the Neuroprotective and Behavioral Effects of Cannabidiol in Hypoxic–Ischemic Newborn Piglets

    Frontiers in Pharmacology, Vol. 13

2021

  1. Engraftment characterization of risk-stratified AML in NSGS mice

    Blood Advances, Vol. 5, Núm. 23, pp. 4842-4854

  2. Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment

    Clinical and Translational Oncology, Vol. 23, Núm. 9, pp. 1801-1810

2019

  1. Bone marrow mesenchymal stem/stromal cells from risk-stratified acute myeloid leukemia patients are anti-inflammatory in in vivo preclinical models of hematopoietic reconstitution and severe colitis

    Haematologica, Vol. 104, Núm. 2, pp. e54-e58

  2. Cannabidiol administration prevents hypoxia-ischemia-induced hypomyelination in newborn rats

    Frontiers in Pharmacology, Vol. 10, Núm. SEP

2017

  1. Neuroprotective effects of cannabidiol in hypoxic ischemic insult. The therapeutic window in newborn mice

    CNS and Neurological Disorders - Drug Targets, Vol. 16, Núm. 1, pp. 102-108

2011

  1. Antihypertensive effects of peroxisome proliferator-activated receptor-β activation in spontaneously hypertensive rats

    Hypertension, Vol. 58, Núm. 4, pp. 733-743